If, from March 27, 2020 through March 30, 2022, both dates inclusive, you purchased the common stock of CytoDyn Inc. for the beneficial interest of a person or entity other than yourself please read the Broker/Nominee letter below with instructions on how to notify your clients:
| DOCUMENT | DESCRIPTION | SIZE | DOWNLOAD |
|---|---|---|---|
| CytoDyn Broker Letter | 778 KB | PDF ↓ |
If you are filing electronic claims:
Representatives with authority to file on behalf of (a) accounts of multiple Settlement Class Members and/or (b) institutional accounts with large numbers of transactions (“Representative Filers”) must submit information regarding their transactions in an electronic spreadsheet format. The instructions and spreadsheet template are below:
Representatives with authority to file on behalf of (a) accounts of multiple Settlement Class Members and/or (b) institutional accounts with large numbers of transactions (“Representative Filers”) must submit information regarding their transactions in an electronic spreadsheet format. The instructions and spreadsheet template are below: